Insider · CIK 0001966698
Brett A. Grimaud
officer
Files at TBPH (Theravance Biopharma, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | DDisposition to issuer Ordinary Shares | -223,917 | - | - | 131,251 | 18 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | DDisposition to issuer Ordinary Shares | -107,812 | - | - | 23,439 | 18 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | DDisposition to issuer Ordinary Shares | -23,439 | - | - | 0 | 18 d ago |
| May 20, 2025 | TBPH Theravance Biopharma, Inc. | FTax withholding Ordinary Shares | -9,743 | $9.45 | $92k | 384,068 | May 22, 2025 |
| Feb 28, 2025 | TBPH Theravance Biopharma, Inc. | AGrant or award Ordinary Shares | +75,000 | $0.00 | $0 | 393,811 | Mar 4, 2025 |
| Feb 20, 2025 | TBPH Theravance Biopharma, Inc. | FTax withholding Ordinary Shares | -14,534 | $9.66 | $140k | 318,811 | Feb 24, 2025 |
| Nov 20, 2024 | TBPH Theravance Biopharma, Inc. | FTax withholding Ordinary Shares | -9,268 | $9.97 | $92k | 333,345 | Nov 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.